• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study.

作者信息

Singh Shailendra, Khan Ahmad

机构信息

West Virginia University, West Virginia University Health Sciences Center, Charleston Division, Charleston, West Virginia; Charleston Area Medical Center Health System, Charleston, West Virginia.

Department of Medicine, West Virginia University Health Sciences Center Charleston Division, Charleston, West Virginia.

出版信息

Gastroenterology. 2020 Aug;159(2):768-771.e3. doi: 10.1053/j.gastro.2020.04.064. Epub 2020 May 4.

DOI:10.1053/j.gastro.2020.04.064
PMID:32376408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7196546/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e9d/7196546/aae754633c72/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e9d/7196546/888767beb0da/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e9d/7196546/aae754633c72/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e9d/7196546/888767beb0da/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e9d/7196546/aae754633c72/fx2_lrg.jpg

相似文献

1
Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study.美国已有肝病患者中2019冠状病毒病的临床特征与转归：一项多中心研究网络研究
Gastroenterology. 2020 Aug;159(2):768-771.e3. doi: 10.1053/j.gastro.2020.04.064. Epub 2020 May 4.
2
Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).西班牙巴斯克地区新冠疫情期间炎症性肠病患者的特征与预后
Gastroenterology. 2020 Aug;159(2):781-783. doi: 10.1053/j.gastro.2020.04.043. Epub 2020 Apr 21.
3
Etiology and management of liver injury in patients with COVID-19.新型冠状病毒肺炎患者肝损伤的病因和处理。
World J Gastroenterol. 2020 Aug 28;26(32):4753-4762. doi: 10.3748/wjg.v26.i32.4753.
4
Determinants of COVID-19 disease severity in patients with cancer.癌症患者 COVID-19 疾病严重程度的决定因素。
Nat Med. 2020 Aug;26(8):1218-1223. doi: 10.1038/s41591-020-0979-0. Epub 2020 Jun 24.
5
Liver diseases in COVID-19: Etiology, treatment and prognosis.COVID-19 相关肝脏疾病：病因、治疗与预后。
World J Gastroenterol. 2020 May 21;26(19):2286-2293. doi: 10.3748/wjg.v26.i19.2286.
6
Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study.美国严重急性呼吸综合征冠状病毒2感染患者胃肠道症状的患病率及特征：一项多中心队列研究
Gastroenterology. 2020 Aug;159(2):765-767.e2. doi: 10.1053/j.gastro.2020.04.045. Epub 2020 Apr 22.
7
Updated Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.更新的影响冠状病毒疾病并发症风险的慢性疾病估计数，美国。
Emerg Infect Dis. 2020 Sep;26(9):2172-5. doi: 10.3201/eid2609.202117. Epub 2020 Jul 3.
8
Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study.美国炎症性肠病患者发生重症2019冠状病毒病的风险：一项多中心研究网络研究
Gastroenterology. 2020 Oct;159(4):1575-1578.e4. doi: 10.1053/j.gastro.2020.06.003. Epub 2020 Jun 6.
9
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.在纽约市医疗系统中 COVID-19 住院患者中的血栓形成。
JAMA. 2020 Aug 25;324(8):799-801. doi: 10.1001/jama.2020.13372.
10
[The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].[新型冠状病毒肺炎肝损伤防治专家共识]
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):217-221. doi: 10.3760/cma.j.cn501113-20200309-00095.

引用本文的文献

1
Case Report: Genetic predisposition to low-dose NSAID-induced liver injury in real-world China.病例报告：中国真实世界中低剂量非甾体抗炎药所致肝损伤的遗传易感性
Front Med (Lausanne). 2025 Jul 24;12:1637289. doi: 10.3389/fmed.2025.1637289. eCollection 2025.
2
Hepatic Decompensation Associated With COVID-19 in a Patient With Alcoholic Liver Cirrhosis: A Case Report.酒精性肝硬化患者合并 COVID-19 所致肝失代偿：一例报告
Cureus. 2025 Jun 23;17(6):e86615. doi: 10.7759/cureus.86615. eCollection 2025 Jun.
3
Recommended vaccinations for patients with chronic liver diseases.

本文引用的文献

1
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.
2
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤：管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
3
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
慢性肝病患者的推荐疫苗接种。
Clin Exp Hepatol. 2025 Mar;11(1):1-8. doi: 10.5114/ceh.2025.148265. Epub 2025 Mar 31.
4
Post COVID Condition and Long-Term COVID-19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study.新冠后状况及长期新冠对肝硬化患者肝失代偿和生存的影响：一项倾向匹配观察性研究
JGH Open. 2025 Mar 24;9(3):e70142. doi: 10.1002/jgh3.70142. eCollection 2025 Mar.
5
Clinical characteristics and the role of IL-6 in acute-on-chronic liver failure patients with or without COVID-19: a multicenter paired cohort study.伴有或不伴有新型冠状病毒肺炎的慢加急性肝衰竭患者的临床特征及白细胞介素-6的作用：一项多中心配对队列研究
Front Cell Infect Microbiol. 2025 Jan 10;14:1471974. doi: 10.3389/fcimb.2024.1471974. eCollection 2024.
6
Clinical outcomes of COVID-19 in patients with liver cirrhosis - a propensity-matched analysis from a multicentric Brazilian cohort.肝硬化患者感染新型冠状病毒肺炎的临床结局——来自巴西多中心队列的倾向匹配分析
BMC Infect Dis. 2025 Jan 15;25(1):68. doi: 10.1186/s12879-024-10424-x.
7
Impact of prior SARS-CoV-2 infection on postoperative recovery in patients with hepatocellular carcinoma resection.既往 SARS-CoV-2 感染对肝细胞癌切除术后恢复的影响。
BMC Gastroenterol. 2024 Sep 17;24(1):317. doi: 10.1186/s12876-024-03412-7.
8
Association between COVID-19 severity with liver abnormalities: A retrospective study in a referral hospital in Indonesia.2019冠状病毒病严重程度与肝脏异常之间的关联：印度尼西亚一家转诊医院的回顾性研究。
Narra J. 2024 Aug;4(2):e816. doi: 10.52225/narra.v4i2.816. Epub 2024 Jun 21.
9
Clinical and Genomic Perspective of SARS CoV-2 Infection in Liver Disease Patients: A Single-Centre Retrospective Study.肝脏疾病患者中严重急性呼吸综合征冠状病毒 2 感染的临床和基因组观点：一项单中心回顾性研究。
Curr Microbiol. 2024 Aug 8;81(9):301. doi: 10.1007/s00284-024-03786-7.
10
The impact of COVID-19 on the clinical course and outcome of patients with cirrhosis: An observational study.2019冠状病毒病对肝硬化患者临床病程及预后的影响：一项观察性研究。
Health Sci Rep. 2024 Jun 23;7(6):e2207. doi: 10.1002/hsr2.2207. eCollection 2024 Jun.
中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models.肝硬化患者肺炎：与死亡率相关的危险因素和预后模型的预测价值。
Respir Res. 2018 Dec 4;19(1):242. doi: 10.1186/s12931-018-0934-5.
6
Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.肝硬化相关免疫功能障碍：特征和临床相关性。
J Hepatol. 2014 Dec;61(6):1385-96. doi: 10.1016/j.jhep.2014.08.010. Epub 2014 Aug 15.
7
Acute respiratory failure complicating advanced liver disease.急性呼吸衰竭并发于晚期肝病。
Semin Respir Crit Care Med. 2012 Feb;33(1):96-110. doi: 10.1055/s-0032-1301738. Epub 2012 Mar 23.